Stocktoria
Immuneering Corp IMRX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-07-30
Chart by TradingView
3/9
Piotroski F — financial health
16.03
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | — | — | $0 | $316,952 | $2.1M |
| Gross profit | — | — | $0 | $158,830 | $926,888 |
| Operating income | -$59.4M | -$64.1M | -$58.4M | -$51.7M | -$33.9M |
| Net income | -$56.0M | -$61.0M | -$53.5M | -$50.5M | -$33.5M |
| Operating cash flow | -$45.3M | -$55.0M | -$49.0M | -$44.1M | -$30.9M |
| Free cash flow | -$45.5M | -$55.1M | -$49.3M | -$44.8M | -$30.9M |
| Total assets | $232.0M | $52.7M | $102.6M | $122.4M | $166.7M |
| Total liabilities | $13.5M | $11.3M | $12.0M | $12.5M | $10.7M |
| Shareholders' equity | $218.5M | $41.4M | $90.6M | $109.9M | $156.0M |
| Ratios | |||||
| Gross margin | — | — | — | 50.1% | 44.6% |
| Operating margin | — | — | — | -16325.8% | -1629.2% |
| Net margin | — | — | — | -15937.3% | -1612.3% |
| FCF margin | — | — | — | -14148.4% | -1486.2% |
| Return on assets | -24.2% | -115.8% | -52.1% | -41.3% | -20.1% |
| Return on equity | -25.6% | -147.5% | -59.0% | -46.0% | -21.5% |
| Current ratio | 17.50 | 5.28 | 11.35 | 13.50 | 27.04 |
| Revenue growth | — | — | -100.0% | -84.8% | -10.0% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 72,875 | $384,051 |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 16.03 (safe)
- Working capital / assets 0.716
- Retained earnings / assets -1.208
- EBIT / assets -0.256
- Equity / liabilities 16.183
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001790340 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.